Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jan 24, 2024
Data Byte

Schizophrenia pipeline: two PDUFA dates and a dozen readouts in 2024

A look ahead to the schizophrenia milestones coming this year, and the mechanisms behind them
BioCentury | Nov 2, 2017
Translation in Brief

A new pocket for D4

Crystal structure paves way to dopamine D4 receptor-selective agonists
BioCentury | Jan 24, 2013
Cover Story

In silico drug design

BioCentury | Jan 17, 2013
Distillery Techniques

Technology: Computational models

BioCentury | Apr 19, 2004
Product Development

Et D2, Brute?

Items per page:
1 - 6 of 6